|
1. |
Irene Walsh, RN, BSN, MSN, National Medical Care Homecare |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 12-17
Preview
|
PDF (587KB)
|
|
摘要:
Irene Walsh is Vice President of Clinical Services and Quality Assurance at National Medical Care Homecare Division in Waltham, Mass. Ms. Walsh graduated from Quincy Hospital School of Nursing, Quincy, Mass; and Old Dominion University, Richmond, Va. She earned her master's degree in nursing from the Medical College of Virginia, Richmond, Va., and is pursuing a doctorate in business and management at Boston University. Ms. Walsh, an INS member, has held faculty positions at Bellarmine College, Department of Nursing, Louisville, Ky, and Old Dominion University. She also has held nursing staff and administrative positions at hospitals throughout the country.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
2. |
Home Infusion of Intravenous Immune Globulin in Human Immunodeficiency Virus–Infected Children |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 18-22
Jan,
Preview
|
PDF (386KB)
|
|
摘要:
Intravenous immune globulin (IVIG) is administered prophylactically to reduce the development of secondary infections in human immunodeficiency virus (HIV)-infected children whose helper-inducer T-cell (CD4) lymphocyte count is greater than 200 cells/ mm3. By progressively crippling the body's immune system, HIV allows opportunistic infections, which account for approximately 90% of AIDS-related deaths, to develop. In a recently published controlled study conducted by the National Institute for Child Health and Development (N Eng J Med 1991:325:73–80), children who received monthly infusions of IVIG experienced significantly more time free of infection. Home administration of IVIG is safe, convenient, and cost-effective. The first dose of IVIG, however, is administered in a hospital or clinic under physician supervision. Mild side effects occur in approximately 3% to 5% of patients; at least 90% of these effects are related to the infusion rate. In this article, a suggested protocol for home administration including commonly reported side effects and precautionary measures of anaphylaxis is presented.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
3. |
Intravenous Cyclophosphamide in Lupus Nephritis |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 23-36
Mary,
Leondike Margaret,
Preview
|
PDF (435KB)
|
|
摘要:
Systemic lupus erythematosus (SLE) is a chronic disorder of the immune system that affects persons of all ages. Figures released by the Lupus Foundation of America, Inc. indicate that approximately 15,000 new cases of SLE are diagnosed each year. This number includes discoid lupus, which is confined to the skin, drug-induced lupus, which manifests SLE-type symptoms that fade when the implicated drug is discontinued, and SLE, which causes inflammation in a number of organs. Of the three types of lupus, only SLE can lead to life-threatening central nervous system and/or renal involvement. By the 1960s, lupus nephritis and progressive renal disease emerged as dominant factors in SLE patient morbidity, and kidney failure had become the most common cause of death.1This manifestation is presently treated with intravenous cyclophosphamide, which improves survival and preserves renal function.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
4. |
Stimulating New Developments Colony‐Stimulating Factors |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 37-43
Dona,
Preview
|
PDF (624KB)
|
|
摘要:
Drug-induced low white-blood-cell counts have long impaired our ability to treat patients. Colony-stimulating factors are now available for intravenous or subcutaneous administration. These glycoproteins act on hematopoietic cells by binding to specific cell surface receptors and by stimulating proliferation, differentiation, commitment, and activation of new white blood cells. A brief overview of patient population, indications, actions, and adverse reactions for hospital or home use is presented.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
5. |
Vascular Access DevicesManagement of Common Complications |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 44-49
Deborah,
Richardson Patricia,
Preview
|
PDF (496KB)
|
|
摘要:
Developments in vascular access technology, along with advances in therapy, have created specific challenges for the intravenous nurse caring for patients with indwelling vascular access devices. The nurse clinician must be aware of clinical and technical complications that may occur, as well as the nursing management of those complications.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
6. |
Catheter‐Related Colonization Associated with Percutaneous Inserted Central Catheters |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 50-54
Susan,
Pauley Nancy,
Vallande Edna,
Riley Nancy,
Jenner Donna,
Preview
|
PDF (438KB)
|
|
摘要:
The intravenous therapy team at Massachusetts General Hospital studied the potential infectious risks of maintaining percutaneous inserted central catheters (PICC) for prolonged periods. Cultures of 100 PICC sites and catheters were performed on removal of the catheters, which had remained in place for 2 to 43 days. The insertion sites and/or proximal or distal segments of the catheters were found to be colonized in 11% of the patients, with distal catheter tips significantly colonized in only four patients. Nine of the patients were colonized at the insertion site. Bacteremia did not occur as a result of the extended dwell time of the catheters.
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
7. |
ERRATUM |
|
Journal of Intravenous Nursing,
Volume 16,
Issue 1,
1993,
Page 55-55
&NA;,
Preview
|
PDF (30KB)
|
|
ISSN:0896-5846
出版商:OVID
年代:1993
数据来源: OVID
|
|